DIRS.INFO The most relevant business & tech news

☆ Earnings playbook: Your guide to the biggest reports this week, including JPMorgan
▼ + stars: | 2024-01-07 | by ( Fred Imbert | ) www.cnbc.com time to read: +6 min

Friday UnitedHealth is set to report earnings before the bell, with a conference call scheduled for 8:45 a.m. JPMorgan Chase is set to report earnings before the market opens. Management has said it will disclose severance costs and job cuts along with fourth quarter earnings." Delta Air Lines is set to report earnings before the bell, followed by a call at 10 a.m. What history shows: Bank of America beats earnings estimates 79% of the time, per Bespoke.

Persons: Wells, John Butters, Butters, UNH, UnitedHealth, CVS, JPMorgan Chase, Hugh Son, Jane, DAL, Leslie Josephs Organizations: JPMorgan Chase, Citigroup, Bank of America, Delta Airlines, CNBC, LSEG, JPMorgan, First, Management, Delta Air Lines, CNBC CNBC, Delta Locations: Wells Fargo

Read previewThe Food and Drug Administration on Friday cleared the way for Florida's first-in-the-nation plan to import lower-priced prescription drugs from Canada, a long-sought approach to accessing cheaper medications that follows decades of frustration with U.S. drug prices. Ron DeSantis signed the plan into law in 2019, but it required federal review and approval by the FDA, which controls prescription drug imports. "These proposals must demonstrate the programs would result in significant cost savings to consumers without adding risk of exposure to unsafe or ineffective drugs," FDA Commissioner Dr. Robert Califf said in a statement. Health officials there previously have suggested their country's prescription drug market is too small to have any real impact on U.S. prices. The U.S. has long had the highest prescription drug prices in the world, with essentially no government limits on what companies can charge.

Persons: —, Florida's, Ron DeSantis, Joe Biden, Donald Trump —, Robert Califf, DeSantis Organizations: Service, Drug Administration, Business, Republican Gov, FDA, Democratic, U.S, Trump, Health Locations: Canada, Mexico, U.S

☆ Getting hot new weight-loss drugs like Wegovy will still be a struggle in 2024
▼ + stars: | 2024-01-04 | by ( ) www.businessinsider.com time to read: +11 min

AdvertisementIf you were hoping that powerhouse weight-loss drugs like Wegovy would be easier to get in 2024, you may be disappointed. Don't expect Medicare coverage any time soonMedicare could play a major role in expanding coverage of weight-loss drugs . Americans' hunger for weight-loss drugs, and the shockwaves it's likely to send through the culture and economy, are only just beginning. He oversees the state employee health plan, which saw costs skyrocket as thousands of workers suddenly started taking weight-loss drugs. People who are already getting weight-loss drugs will be able to keep taking them.

Persons: —, Renee Rayburg, Mercer, Eli Lilly's, Jose Luis Pelaez, there's, Wegovy, Bill Coyle, ZS, Eli Lilly, David Risinger, Lilly, Risinger, Morgan Stanley, Mounjaro, They're, That's, Patrik Jonsson, Lilly USA, Coyle, Dale Folwell, Folwell Organizations: Service, Pharmaceutical, Group, Novo Nordisk's Wegovy, Mayo Clinic, University of Texas, Hennepin Healthcare, Medicare, Capital Alpha Partners, Vanderbilt University, Nordisk's Wegovy, Novo Nordisk, pharma, Nordisk's, FDA, Pharma, UBS BioPharma Conference, Walmart, Jefferies, Nordisk Locations: Mounjaro, Government, Minnesota, Minneapolis, Hennepin, ZS, U.S, Carolina, North Carolina

☆ One health-insurance startup is bucking the industrywide funding slowdown
▼ + stars: | 2024-01-04 | by ( ) www.businessinsider.com time to read: +3 min

Read previewThe insurance startup Devoted Health managed to raise another $175 million last week despite the venture-capital downturn. Devoted has raised more than $2 billion in funding to date. Funding raised by Devoted and other health-insurance startups isn't included in these figures. New funding follows rapid growthDevoted said the Series E funding round came after a year of fast growth. The round was led by a syndicate that included The Space Between, Highbury Holdings, GIC, Stardust Equity, Maverick Ventures, and Fearless Ventures, Devoted said.

Persons: —, Bill Evans, megadeals, Oscar, Andreessen Horowitz, Catalyst Organizations: Service, Business, Rock Health Capital, Rock Health, Bright, Clover Health, Oscar Health, Highbury Holdings, Stardust Equity, Maverick Ventures, Fearless Ventures, Socium Ventures, Emerson, Prime Capital Partners, GreatPoint Ventures Locations: Waltham , Massachusetts

☆ The first step to setting an annual budget: Figuring out your net income
▼ + stars: | 2023-12-30 | by ( Juhohn Lee | ) www.cnbc.com time to read: +2 min

However, setting a budget goes a long way in managing your personal finances. "Many people spend time doing a New Year's resolution," said Kamila Elliott, a certified financial planner at Collective Wealth Partners. "Knowing your income is extremely important because you know exactly how much you have to deploy," explained Elliott. The final step is setting a goal. Watch the video to find out more about how to set an annual budget for the New Year.

Persons: Kamila Elliott, Elliott Organizations: BMO Financial Group, Wealth Partners, Social Security, CNBC's

☆ The CEO of an A16z-backed healthcare startup is pitching a better way to save money on obesity care
▼ + stars: | 2023-12-29 | by ( ) www.businessinsider.com time to read: +8 min

Boyarsky Pratt said about 35% of Knownwell's patients come for primary care, while the rest see the company's providers for their metabolic health. They can prescribe GLP-1 drugs, but they're just one tool the company uses to treat obesity, Boyarsky Pratt said. It's also planning to partner with more health systems to help them expand access to weight care. It partners with one large system in Massachusetts now, but Boyarsky Pratt declined to disclose which one. "The data shows that the earlier patients get into a comprehensive treatment, the better for the long-term course of the disease," Boyarsky Pratt said.

Persons: —, Brooke Boyarsky Pratt, Andreessen Horowitz, Boyarsky Pratt, Knownwell, Angela Fitch, Berkadia, Fitch, Needham, Boyarsky Platt, they'd, Michael Siluk, It's Organizations: Service, Business, GLP, BMI, Medicare, Obesity Medicine Association . Obesity Medicine, University of Pennsylvania, Harvard Business School, Berkshire Hathaway, Obesity Medicine Association, Weight, Flare Capital Partners, Staff, Getty, American Academy of Pediatrics Locations: Boston, GLP, Massachusetts, Knownwell, Needham , Massachusetts, telehealth

☆ Why we see a way forward for Nvidia in China — plus our take on 2 other stocks in the news
▼ + stars: | 2023-12-13 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +8 min

Meanwhile, Jim Cramer's interview with an influential member of President Joe Biden's cabinet proved encouraging for Club holding Nvidia . It's been a two-session roller-coaster ride that illustrates the importance of staying disciplined and not chasing stocks while they're surging for non-fundamental reasons. Traders were trying to front-run the official announcement, pushing Linde stock up 4.53% Tuesday, to an all-time high of $426.72 per share. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Nvidia CEO Jen-Hsun Huang at the Consumer Elctronics Show (CES) in Las Vegas, USA, 04 January 2017.

Persons: Linde, Jim Cramer's, Joe Biden's, It's, Pfizer's, drugmaker Seagen, there's, Gina Raimondo, Jim, Biden, Raimondo, " Raimondo, Cigna, Humana's, —, Humana, Aetna's, Jim Cramer, Jen, Hsun Huang, Huang, Andrej Sokolow Organizations: Club, Nvidia, LIN, Linde, Nasdaq, Traders, . Commerce, U.S, Bank of America, Wall Street Journal, Humana, CNBC, Consumer, Audi, Getty Locations: China, U.S, Wall, Las Vegas, USA

☆ A merger between Cigna and Humana that would have created a gigantic $140 billion healthcare conglomerate has been called off
▼ + stars: | 2023-12-10 | by ( Kenneth Niemeyer | ) www.businessinsider.com time to read: +3 min

Cigna and Humana called off a potentially massive merger. Cigna still believes a merger with Humana has merit, The Wall Street Journal reported. AdvertisementCigna is giving up on its merger with Humana, which would have created a healthcare giant worth $140 billion, according to reports. This revelation caused Cigna stock to drop nearly 10% as investors began to question the wisdom of using the company's stock as currency, according to the outlet. Instead of the merger Cigna is planning an additional $10 billion of stock buybacks, The Wall Street Journal reported.

Persons: Humana, —, Cigna, David Balto Organizations: Humana, Street Journal, Service, Cigna, UnitedHealth Group, Business, Wall Street, Wall Street Journal, Biden, Antitrust, Federal Trade Commission

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. In a 15-second video released to YouTube on Wednesday night, President Joe Biden promised the move would lower prices. It's the latest health policy pitch from a White House gearing up to make its efforts to tackle drug prices a central theme in next year's reelection campaign. Pharmaceutical companies have pushed back on the idea that prices alone are enough for Washington to act against a drug's patent. The plan could threaten future drugs, according to the pharmaceutical lobbying firm Pharmaceutical Research and Manufacturers of America, or PhRMA.

Persons: —, Biden, Joe Biden, Elizabeth Warren of Massachusetts, Amy Klobuchar, Neera Tanden, Megan Van Etten, William Pierce, George W, Pierce Organizations: Service, Business, YouTube, White, Medicare, Health, Human Services, Pharmaceutical, Pharmaceutical Research, Manufacturers of America, HHS Locations: WASHINGTON, Sens, Minnesota, Washington

Updating your name with the credit bureaus can prevent delays in credit applications and other credit reporting errors. Hinterhaus Productions/Getty ImagesTransgender and nonbinary people can report their legal name change to credit bureaus. One of the many steps in your legal transition is to report your legal name change to all three credit bureaus — Experian, Equifax, and TransUnion — so it'll appear on your credit report. Its also recommended that you change your name with each of your lenders before updating your name with the credit bureaus. Box 4500Allen, TX 75013TransUnionUnlike the other two credit reporting bureaus, TransUnion requires you to change your legal name with every individual financial institution listed on their credit report first.

Persons: Hinterhaus, —, there's, TransUnion, Ryan Klippel, Klippel, folx, you'll, Experian Experian, Allen, it's Organizations: Social Security, Service, Optas, Social, TransUnion, National Center for Transgender Equality, UC Berkeley, Google, Security Locations: myEquifax, Allen , TX, Chester , PA, California

☆ The Best TV Shows of 2023: Giving the Small Screen a Tweak
▼ + stars: | 2023-12-06 | by ( John Anderson | ) www.wsj.com time to read: 1 min

Illustration: Sean McCabeIt wasn’t a regular year, this 2023. Writers were on strike; actors were on strike. Martha the Medicare Lady was making people crazier than they already were. That said, I had assumed that this retrospective examination and contemplation of TV in the year ’23 was destined to be about the new. Hence the flourishing business of game shows, “unscripted” celebrity-reality series and nonfiction programming about serial murderers, which are always comforting to those of us not being murdered.

Persons: Sean McCabe, lurched, Martha

☆ US drug shortages are forcing ‘impossible choices’ for Americans, experts tell Senate committee
▼ + stars: | 2023-12-05 | by ( Jen Christensen | ) edition.cnn.com time to read: +7 min

Anderson Cancer Center in Houston, Dr. Jason Westin regularly witnesses the power of lifesaving cancer drugs. But because generic cancer drugs are often in shortage in the United States, he says, he and his patients have been put in a terrible position. Makers of generic drugs don’t have to share information about the supply chain, so buyers currently choose based only on price. Hernandez told the Senate committee that of the top 50 generic drugs paid for by Medicare Part D, 16 were marked up 1,000% or higher. Until there is some kind of legislation that addresses drug shortages, Wosińska and the other experts agreed, they will continue.

Persons: Jason Westin, ” Westin, that’s, they’d, Sen, Marsha Blackburn, Mike Crapo, Generics, ” Crapo, “, ”, Crapo, Inmaculada Hernandez, ” Hernandez, Dr, Marta E, it’s, ” Wosińska, Ron Wyden, ” Wyden, Hernandez, Sanjay Gupta Organizations: CNN, Anderson Cancer Center, US, Finance, Vanderbilt, Tennessee Republican, Food and Drug Administration, Westin, Skaggs School of Pharmacy, Pharmaceutical Sciences, University of California, Centers, Medicare, Medicaid Services, Brookings Institution, CNN Health Locations: M.D, Houston, United States, Nashville, Idaho, China, India, San Diego, Oregon, generics

☆ Here’s where to invest your cash to save on taxes in 2024
▼ + stars: | 2023-12-04 | by ( Kate Dore | Cfp | ) www.cnbc.com time to read: +1 min

"While any additional income earned from higher yields is taxed at a progressively higher rate, IRMAA applies as a surcharge," he said. "This means that even $1 of additional income could trigger higher premiums." With terms ranging from one month to one year, most Treasury bills, known as T-bills, are currently paying well over 5%, as of Dec. 4. However, T-bills offer a tax benefit over products like high-yield savings, certificates of deposit or money market funds: no state or local taxes on earnings. T-bill interest is still subject to federal income taxes.

Persons: Eric Audras, Mullikin, Catherine Valega Organizations: PhotoAlto, Getty, Medicare, Green Bee Locations: Boston, TreasuryDirect

☆ Stephanie Armour — Senior Special Writer, Healthcare Policy at The Wall Street Journal
▼ + stars: | 2023-12-02 | by ( Stephanie Armour | ) www.wsj.com time to read: +1 min

Stephanie ArmourStephanie Armour is a senior special writer for health policy at The Wall Street Journal, where she covers such topics as the Covid-19 pandemic, the Affordable Care Act, Medicaid and Medicare, congressional health legislation, the opioid epidemic, and state health initiatives. A reporter for more than two decades, she has produced award-winning investigative projects on subjects including food safety, body brokering, and human trafficking. Stephanie also has written for Bloomberg and Bloomberg Businessweek, USA Today, The Des Moines Register, and The Daily Tribune in Ames, Iowa. Her journalism awards include a First Place Headliner Award from the Press Club of Atlantic City, a First Place Sigma Delta Chi Award from the Society of Professional Journalists and a First Place in Consumer Journalism Award from the National Press Club. She lives in Washington D.C. and has a degree in English from the University of Minnesota.

Persons: Stephanie Armour Stephanie Armour, Stephanie Organizations: Wall Street, Affordable, Bloomberg, Bloomberg Businessweek, USA, Des Moines Register, The Daily Tribune, Press, Sigma Delta Chi, Society of Professional Journalists, Consumer, National Press, Washington D.C, University of Minnesota Locations: Ames , Iowa, Atlantic City, Washington

☆ Mallinckrodt Avoids $40 Million SEC Fine in Medicaid Overcharge Case
▼ + stars: | 2023-12-02 | by ( David Smagalla | ) www.wsj.com time to read: 1 min

Mallinckrodt didn’t admit or deny the SEC’s findings. Photo: Whitney Curtis/Associated PressThe U.S. Securities and Exchange Commission said Mallinckrodt failed to tell investors it had potentially overcharged Medicaid for its flagship drug, but the regulator waived a $40 million civil penalty partly because the pharmaceutical company agreed to hire a compliance consultant. The SEC said in an administrative proceeding Thursday that the Centers for Medicare and Medicaid Services informed Mallinckrodt as early as 2016 that the company was using an incorrect rebate rate for its sales of Acthar Gel, a drug used to treat several rare autoimmune diseases, which meant it was overcharging state Medicaid programs for the drug.

Persons: Mallinckrodt didn’t, Whitney Curtis, Mallinckrodt Organizations: Associated Press, U.S . Securities, Exchange Commission, SEC, Medicare, Services

☆ Trump is picking a dumb fight that could cost him dearly
▼ + stars: | 2023-12-02 | by ( Brent D. Griffiths | ) www.businessinsider.com time to read: +4 min

Because once again, we are talking about repealing Obamacare. AdvertisementAs a result, Trump has handed President Joe Biden a potent gift at a critical time. Despite over a decade of promises of "repealing and replacing" Obamacare, Republicans have never agreed on how to replace the law. AdvertisementIn reigniting the repeal debate, Trump has also opened up the playbook for the Biden White House. Unlike typical Republicans, Trump professes an aversion to cutting Social Security and Medicare (even if the actual reality isn't the same.)

Persons: Donald Trump, Biden, —, Trump, Joe Biden, it's, Jody, Ron DeSantis, Kim Reynolds hasn't, Obamacare, Trump's Organizations: Obamacare, Service, Wall, Hamas, NBC, Republicans, Florida Gov, Iowa Gov, GOP, Politico, Biden White House, Social Security, Medicare, White Locations: Nevada, Florida

☆ What to Know About Home Care Services
▼ + stars: | 2023-12-02 | by ( Reed Abelson | More About Reed Abelson | ) www.nytimes.com time to read: +1 min

And most middle-class people will have to pay for home care themselves if they will need it for the long haul. After a fall or surgery, some older people will need short-term care at home from a nurse or therapist to help them recover. Medicare, the federal insurance program for those 65 and over, typically pays for this kind of home health care. They need a home health aide or personal care assistant, who may not have much, if any, medical training. A wide range of services are available, whether it’s light housekeeping or hiring a private-duty nurse.

Persons: Monica Moreno Organizations: Medicare, Alzheimer’s Association

☆ Competition will make obesity drugs successful
▼ + stars: | 2023-12-01 | by ( Robert Cyran | ) www.reuters.com time to read: +3 min

In an interview with the Financial Times, he proposed spreading reimbursements over time if the medication proves to be successful. There’s some practical grounding in that solution, but the path of other similar drugs suggests that a competitive market is a better way to make it successful. Snag is, the drugs cost several thousand dollars per patient annually, even after discounts. Medicare, which covers 66 million seniors, can’t pay for weight loss drugs under current law. While it makes more sense for insurers or governments to pay over time if the drugs benefits last, schemes like the one that Jørgensen suggests can only do so much.

Persons: Lars Fruergaard Jørgensen, Jørgensen, “, Lauren Silva Laughlin, Sharon Lam Organizations: Reuters, Novo Nordisk, Financial Times, Centers for Disease Control, Prevention, North Carolina, The New England, of Medicine, Employers, Thomson Locations: U.S, The, United States, Danish

☆ Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
▼ + stars: | 2023-12-01 | by ( ) www.reuters.com time to read: +23 min

Novo spent at least $25.8 million over the past decade on U.S. medical professionals to promote its two obesity drugs, Wegovy and Saxenda, the analysis found. Jastreboff has also worked on clinical trials of obesity drugs for Eli Lilly, which markets a Wegovy competitor. Some doctors said Novo’s payments exemplify how the flood of industry money can dominate decision-making about care and coverage. Government pharmacy officer Solaru said her agency concluded that the new obesity drugs could be cost-effective by preventing other weight-related diseases and boosting workplace productivity. In January, the personnel office told its health plans they must cover at least one GLP-1 obesity drug for 8 million workers, retirees and family members.

Persons: Lee Kaplan, Kaplan, ”, gastroenterologist, He’s, Novo, Donna Ryan, Ryan, “, ” Kaplan, ” Novo, Robert Lustig, “ I’m, Lustig, They’re, Ania, ” Jastreboff, Jastreboff, Eli Lilly, Lilly’s Zepbound, Lilly, ” Lilly, Novo’s, Ayana, Sanders, Arthur Kellermann, ” Kellermann, mouthpieces, ’ ”, “ I'm, Jamy Ard, Ard, Dele, ” Solaru, ” Ryan, Scott Kahan, Kahan, Solaru, Christine Gallagher, Wegovy, Rebekah Carl, Carl, Jen Wexler, gaunt, Wexler Organizations: Novo Nordisk, Dartmouth, Nutrition Institute, Massachusetts General Hospital, Harvard Medical School, Reuters, Cambridge, Obesity Society, U.S ., Management, Reuters . Pharmaceutical, ”, U.S, United, National Health Service, University of California, U.S . Food, Drug Administration, Doctors, Wegovy’s, BMI, Yale University’s Center, Weight Management, Wall Street, American Medical Association, Rutgers University’s School of Public Health, Affordable, . Pharmaceutical, Companies, Uniformed Services University of Health Sciences, Wake Forest University, Wake Forest Baptist Health Weight Management, Obesity, Pennington Biomedical Research, U.S . National Institutes of Health, Personnel Management, Coalition, STOP, George Washington University, Novo Locations: CAMBRIDGE, Massachusetts, Boston, U.S, Novo, Danish, United States, Louisiana, San Francisco, Wegovy, Pennington, Baton Rouge , Louisiana, Government, New Columbia , Pennsylvania, Florida

☆ Jim Cramer explains why it's hard to be bullish on the healthcare sector
▼ + stars: | 2023-11-30 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Thursday told investors why it's hard to be bullish about healthcare stocks, citing challenges stemming from government action and lack of innovation. According to Cramer, the healthcare sector is "in the crosshairs" of the U.S. government because of the upcoming election. Johnson & Johnson and Bristol Meyers are among several drug makers to file lawsuits against the government, broadly arguing that the pricing measures are unconstitutional. The Federal Trade Commission is doing its best to block mergers in the sector, Cramer said. Aside form drug makers, Cramer added that medical device companies haven't seen their business pick up since Covid, also hurting the sector overall.

Persons: CNBC's Jim Cramer, Cramer, Johnson, Bristol Meyers, Eli Lilly Organizations: Biden Administration, Johnson, Federal Trade Commission Locations: Cigna

☆ Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators
▼ + stars: | 2023-11-30 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +3 min

That's a major reason why we took a stake in the company in April 2022 and a key growth area for the health insurance industry overall. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Cigna, I've, Jim, It's, That's, Joe Biden, Biden, Lina Khan, Jim Cramer's, Ty Wright Organizations: Street, Humana, Express, Aetna, CVS Health, Cigna, Federal Trade Commission, Justice Department, FTC, CNBC, Bloomberg, Getty Locations: U.S, Louisville , Kentucky

☆ AbbVie to buy cancer drugmaker ImmunoGen for $10 billion as Humira faces heat
▼ + stars: | 2023-11-30 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Brian Snyder/File Photo Acquire Licensing RightsNov 30 (Reuters) - AbbVie (ABBV.N) will buy ImmunoGen (IMGN.O) for $10.1 billion in cash, it said on Thursday, the latest major drugmaker to buy a developer of 'guided missile' cancer therapies as the company's top-seller Humira grapples with fierce competition. ImmunoGen's Elahere belongs to a new class of treatments called antibody-drug conjugates (ADC) that precisely targets cancer cells, potentially reducing toxicity for other cells. The drug, approved for ovarian cancer patients who have received previous therapies, is also being tested in earlier lines of treatment. AbbVie will also get access to Immunogen's follow-on pipeline of ADCs, including early-stage ovarian cancer candidate IMGN-151 and a mid-stage drug pivekimab sunirine for a rare type of blood cancer. Meanwhile, AbbVie's cancer drugs sales declined more than 8% in the third quarter to $1.51 billion, primarily due to increased competition to Imbruvica.

Persons: Brian Snyder, ImmunoGen's Elahere, AbbVie, IMGN, pivekimab, Immuogen stock's, Immunogen's, Elahere, Imbruvica, Manas Mishra, Leroy Leo, Shinjini Ganguli Organizations: REUTERS, Pfizer, Merck, U.S, Thomson Locations: Cambridge , Massachusetts, U.S, Bengaluru

☆ Why a giant health insurer merger is probably destined to fail
▼ + stars: | 2023-11-30 | by ( ) www.businessinsider.com time to read: +7 min

The giant health insurers Cigna and Humana are reportedly considering a merger. While they offer different kinds of health insurance, the deal is likely to face antitrust scrutiny. Still, Cigna and Humana did toy with a deal way back in 2014 before they pursued deals with other partners. Later, to sidestep antitrust scrutiny, health insurers eyed mergers with other pieces of the healthcare system outside of insurance. Cigna and Humana would face a more skeptical Justice DepartmentAny deal between health insurers the size of Cigna and Humana would have to get past the Justice Department's antitrust enforcers.

Persons: Biden, —, Justice that's, BofA, David Balto, Cigna, That's, Balto, Barak Richman, there's, Matthew Cantor, Constantine Cannon, divestitures aren't, Molina wouldn't, Cantor Organizations: Humana, Service, Reuters, Bloomberg, Street, Department, Justice, Cigna, UnitedHealth Group, Equity, Federal Trade Commission, Justice Department, Express, CVS Health, Aetna, Kindred, Biden Administration, FTC, Duke University Locations: Cigna, Aetna, Delaware

DENVER (AP) — President Joe Biden will try to turn Rep. Lauren Boebert of Colorado into the embodiment of Republican opposition to his agenda as he visits her congressional district on Wednesday. Biden plans to tour CS Wind, the world’s largest facility for wind tower manufacturing, in the town of Pueblo. The White House said the data indicates that Biden's policies are expanding economic opportunity. He spoke at a Tuesday night fundraiser in Denver, where he said Trump and Republicans wanted to abandon his administration's efforts. Biden also said Republicans want to cut Social Security and Medicare, benefits that are crucial for many elderly Americans.

Persons: Joe Biden, Lauren Boebert, Biden, Donald Trump, MAGA, Boebert, Adam Frisch, Rosalynn Carter, Jimmy Carter, Trump, “ We’re, ” Biden, ”, “, ___ Megerian Organizations: DENVER, Republicans, CS, Democratic, Treasury Department, White, MAGA Republicans, Congressional, Social Security, Pueblo Locations: Colorado, Pueblo, Israel, Pennsylvania, ”, Atlanta, Denver, America, United States, Washington

☆ Cigna, Humana shares fall after report health-care giants are in talks to merge
▼ + stars: | 2023-11-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Shares of Cigna and Humana slid Wednesday after a report that the two health-care giants are in talks to merge. A Cigna spokesperson did not immediately respond to CNBC's request for comment on the report from The Wall Street Journal, which cited people familiar with the matter. A Humana spokesperson declined to comment. A Cigna spokesperson at the time said the company does not comment on "rumors or speculation." Some analysts have suggested that a potential combination with Humana could be a reason for Cigna to offload its Medicare Advantage business.

Persons: Humana's, Cigna, Scott Fidel, Stephens, Fidel Organizations: Humana, Wall Street, STAT, CNBC PRO

Search resuls for: "Medicare"

25 mentions found